Individuals with ARTHS present with developmental delay, cognitive impairment (100% penetrance), delay or absence of speech (100%), facial dysmorphism (85%), feeding difficulties (78%), and neonatal hypotonia (76%) in a study of 76 individuals with KAT6A mutations (Kennedy et al, 2019)
View this story on The Korea Herald RELATED CONTENT RELATED TOPICS Topic Health Science
Murray Avenue Apothecary is not responsible for the opinions or comments posted on this website, and does not necessarily share the opinions, views or commentary of postings on this website
Genediet interactions in brain aging and neurodegenerative disorders
Compounds with genuine therapeutic potential attract investment, progress through trials, and eventually reach the market